Msi-H/DMMR gastroesophageal-junction cancer

Clinical trials for Msi-H/DMMR gastroesophageal-junction cancer explained in plain language.

Never miss a new study

Get alerted when new Msi-H/DMMR gastroesophageal-junction cancer trials appear

Sign up with your email to follow new studies for Msi-H/DMMR gastroesophageal-junction cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 2

New hope for advanced cancers: experimental drug EIK1005 enters human trials

Disease control Recruiting now

This study tests a new drug called EIK1005, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the drug shrinks tumors. About 160 adults with certain cancer types…

Matched conditions: MSI-H/DMMR GASTROESOPHAGEAL-JUNCTION CANCER

Phase 1/2 • Sponsor: Eikon Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

Msi-H/DMMR gastroesophageal-junction cancer

Get alerted when new Msi-H/DMMR gastroesophageal-junction cancer trials appear

New hope for advanced cancers: experimental drug EIK1005 enters human trials